Seventeen tumours (3.5%) had complete tumour regression (ypT0), 29 tumours (6%) were ypT1, 42 tumours (9%) ypT2, 239 tumours (50%) ypT3 and 153 tumours (32%) were in the ypT4 category. Here, RAB11B is linked to neoplasm.